SCHEMBL3170077

SCHEMBL3170077

CN(C)c1c(C(=O)O)c(=O)oc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.60
▸ CA12 O43570 2/20 0.53
▸ CA9 Q16790 2/20 0.53
▸ KDM4E B2RXH2 6/20 0.47
▸ MAPT P10636 3/20 0.47
▸ NQO1 P15559 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ GPR55 Q9Y2T6 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ LMNA P02545 2/20 0.45
▸ USP2 O75604 1/20 0.44
▸ CSNK2A2 P19784 1/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ CSNK2B P67870 1/20 0.44
▸ CSNK2A1 P68400 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31222315 1.00 GAA (0.60) GAACA12CA9KDM4EMAPT
SCHEMBL4953673 0.88 GAA (0.57) GAACA12CA9KDM4EMAPT
SCHEMBL1397191 0.84 GAA (0.56) GAACA12CA9KDM4EMAPT
SCHEMBL1957427 0.84 ALDH1A1 (0.49) GAACA12CA9KDM4EMAPT
SCHEMBL7753264 0.80 CA12 (0.57) GAACA12CA9KDM4EMAPT
SCHEMBL16397724 0.80 NQO1 (0.46) GAACA12CA9KDM4ENQO1
SCHEMBL2808497 0.79 KDM4E (0.57) GAACA12CA9KDM4EMAPT
SCHEMBL30776764 0.79 KDM4E (0.57) GAACA12CA9KDM4EMAPT
SCHEMBL10702500 0.78 MAPT (0.51) GAACA12CA9KDM4EMAPT
SCHEMBL1660190 0.78 GAA (0.70) GAACA12CA9KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1590479-B1 NUCLEIC ACID AMPLIFICATION GE HEALTHCARE BIO SCIENCES (US) 2010-11-24 — — EP disclosed
EP-1421213-B1 LABELED NUCLEOSIDE POLYPHOSPHATES GE HEALTHCARE BIO SCIENCES (US) 2010-02-17 — — EP disclosed
EP-1597602-A4 SOLID PHASE SEQUENCING GE HEALTHCARE BIO SCIENCES (US) 2009-07-22 — — EP disclosed
US-7393640-B2 Terminal-phosphate-labeled nucleotides with new linkers GE HEALTHCARE BIO-SCIENCES CORP. (US) 2008-07-01 — — US disclosed
EP-1592779-A4 TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS GE HEALTHCARE BIO SCIENCES (US) 2007-12-12 — — EP disclosed
US-7125671-B2 Nucleic acid amplification with terminal-phosphate labeled nucleotides GE HEALTHCARE BIO-SCIENCES CORP. (US) 2006-10-24 — — US disclosed
US-7041812-B2 Labeled nucleoside polyphosphates AMERSHAM BIOSCIENCES CORP (US) 2006-05-09 — — US disclosed
EP-1590479-A4 NUCLEIC ACID AMPLIFICATION AMERSHAM BIOSCIENCES CORP (US) 2006-04-05 — — EP disclosed
EP-1421213-A4 LABELED NUCLEOSIDE POLYPHOSPHATES AMERSHAM BIOSCIENCES CORP (US) 2005-12-28 — — EP disclosed
EP-1597602-A2 SOLID PHASE SEQUENCING Amersham Biosciences Corp. (US) 2005-11-23 — — EP disclosed
EP-1592779-A2 TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS Amersham Biosciences Corp. (US) 2005-11-09 — — EP disclosed
EP-1590479-A1 NUCLEIC ACID AMPLIFICATION Amersham Biosciences Corp. (US) 2005-11-02 — — EP disclosed
WO-2004071155-A2 SOLID PHASE SEQUENCING AMERSHAM BIOSCIENCES CORP (US) 2004-08-26 — — WO disclosed
WO-2004072238-A2 TERMINAL-PHOSPHATE-LABELED NUCLEOTIDES WITH NEW LINKERS AMERSHAM BIOSCIENCES CORP (US) 2004-08-26 — — WO disclosed
WO-2004072304-A1 NUCLEIC ACID AMPLIFICATION AMERSHAM BIOSCIENCES CORP (US) 2004-08-26 — — WO disclosed
EP-1421213-A2 LABELED NUCLEOSIDE POLYPHOSPHATES Amersham Biosciences Corp. (US) 2004-05-26 — — EP disclosed
WO-2003020734-A2 LABELED NUCLEOSIDE POLYPHOSPHATES AMERSHAM BIOSCIENCES CORP (US) 2003-03-13 — — WO disclosed
Send feedback